Last reviewed · How we verify

NCT06276413: REBRA

REgistRy BRAnch goRE EndopRosthEsis

Not yet recruiting Last updated 26 February 2024
What this trial tests

trial testing GORE TAG Thoracic Branch Endoprosthesis in Aortic Aneurysm, Thoracic in 50 participants. Not yet recruiting.

Timeline
1 March 2024
Primary endpoint
31 December 2025
31 December 2030

Quick facts

Lead sponsorUniversity Hospital Padova
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment50
Start date1 March 2024
Primary completion31 December 2025
Estimated completion31 December 2030
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Padova

Who can join

18 and older, any sex, with Aortic Aneurysm, Thoracic or Aortic Dissection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multicenter registry on patients treated by the new Gore thoracic branched endoprosthesis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Aneurysm, Thoracic

Currently open trials in the same condition.

Other University Hospital Padova trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06276413.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing